Amneal Pharmaceuticals (AMRX) Accumulated Expenses (2018 - 2019)
Amneal Pharmaceuticals (AMRX) recorded quarterly Accumulated Expenses of $36.0 million in Q4 2019, down 53.28% quarter-over-quarter from $77.1 million in Q4 2018, and down 53.28% on a YoY basis from $77.1 million in Q4 2018.
Amneal Pharmaceuticals (AMRX) Accumulated Expenses (2018 - 2019) Analysis & Trends
Amneal Pharmaceuticals' Accumulated Expenses history runs 2 years deep, the most recent figure standing at $36.0 million for Q4 2019.
- In Q4 2019, Accumulated Expenses fell 53.28% year-over-year to $36.0 million; the TTM figure through Dec 2019 stood at $36.0 million (down 53.28% YoY), while the FY2019 annual figure was $36.0 million, down 53.28% from the prior year.
- Accumulated Expenses was $36.0 million for Q4 2019 at Amneal Pharmaceuticals, down from $77.1 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $77.1 million in Q4 2018 to a low of $36.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Amneal Pharmaceuticals | 4.66 Bn | 4.65 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.01 Mn |
| Dec 31, 2018 | 77.07 Mn |